Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Return on Capital Employed: 2011-2019

Historic Return on Capital Employed for Neurocrine Biosciences (NBIX) over the last 9 years, with Dec 2019 value amounting to 0.12%.

  • Neurocrine Biosciences' Return on Capital Employed fell 10.00% to 0.05% in Q3 2021 from the same period last year, while for Sep 2021 it was 0.05%, marking a year-over-year decrease of 10.00%. This contributed to the annual value of 0.12% for FY2019, which is 8.00% up from last year.
  • As of FY2019, Neurocrine Biosciences' Return on Capital Employed stood at 0.12%, which was up 174.00% from 0.05% recorded in FY2018.
  • In the past 5 years, Neurocrine Biosciences' Return on Capital Employed registered a high of 0.12% during FY2019, and its lowest value of -0.38% during FY2016.
  • In the last 3 years, Neurocrine Biosciences' Return on Capital Employed had a median value of 0.05% in 2018 and averaged -0.03%.
  • In the last 5 years, Neurocrine Biosciences' Return on Capital Employed fell by 10bps in 2016 and then climbed by 29bps in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Return on Capital Employed (Yearly) stood at -0.28% in 2015, then fell by 10bps to -0.38% in 2016, then increased by 13bps to -0.24% in 2017, then grew by 29bps to 0.05% in 2018, then increased by 8bps to 0.12% in 2019.